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 Patient-controlled Epidural Analgesia with Ropivacaine 
and Fentanyl: Experience with 2,276 Surgical Patients
　Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, 
Yonsei University College of Medicine, Seoul, Korea 
Shin Hyung Kim, MD, Kyung Bong Yoon, MD, Duck Mi Yoon, MD, 
Chan Mi Kim, MD, and Yang Sik Shin, MD
Background: 
Good postoperative pain control is an important part of adequate postoperative care. Patient-controlled 
epidural analgesia (PCEA) provided better postoperative analgesia compared to other conventional analgesic 
methods, but several risks have been observed as well. We therefore surveyed the efficacy and safety of PCEA 
in this retrospective observational study. 
Methods: 
We analyzed collected data on 2,276 elective surgical patients who received PCEA with ropivacaine and 
fentanyl. Patients were assessed by a PCA service team in the post-anesthesia care unit (PACU), at 1−6 h, 
6−24 h, and 24−48 h postoperatively for adequate pain control. The presence of PCEA-related adverse events 
was also assessed.
Results: 
Numerical pain score (median [interquartile range]) were 3 [1−4], 5 [4−7], 4 [3−5], and 3 [3−5] in the 
PACU, at 1−6 h, 6−24 h, and 24−48 h postoperatively. Median pain scores in patients underwent major 
abdominal or thoracic surgery were higher than other surgical procedure in the PACU, at 1−6 h after surgery. 
Nausea and vomiting (20%) and numbness and motor weakness (15%) were revealed as major PCEA-related 
adverse events during the postoperative 48 h period. There were 329 patients (14%) for whom PCEA was ceased 
within 48 h following surgery.
Conclusions: 
Our data suggest that the use of PCEA provides proper analgesia in the postoperative 48 h period after a 
wide variety of surgical procedures and that is associated with few serious complications. However, more careful 
pain management and sustainable PCEA monitoring considering the type of surgical procedure undergone is 
needed in patients with PCEA. (Korean J Pain 2013; 26: 39-45)
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INTRODUCTION 
The provision of high-quality analgesia in the post-
operative period is important, not only to relieve post-sur-
gical pain and improve well-being, but also because in-
adequate pain control may increase morbidity, lead to pro-
longed hospital stays, and increase medical costs [1,2]. 
Patient-controlled epidural analgesia (PCEA) is a widely 
used postoperative analgesic strategy because it is an ef-
fective and safe method of acute postoperative pain relief 
[3-5]. Previous large-scale analysis has demonstrated that 
PCEA provides better postoperative analgesia compared to 
parenteral opioids or intravenous patient-controlled an-
algesia (IV-PCA) [3,6]. However, severe complications of 
PCEA, such as respiratory depression, epidural hematoma, 
and catheter-related infections can threaten the safety of 
patients [6]. Moreover, early cessation of PCEA due to side 
effects or complications may not only lead to patient dis-
comfort, but also to dissatisfaction with postoperative pain 
management and an increase in medical costs as well [7]. 
Therefore, an investigation of the actual conditions of 
PCEA use is clinically significant. There are now several 
published studies detailing experiences with large numbers 
of patients who received postoperative PCEA [8-10]. 
Unfortunately, there have not been any published studies 
detailing the efficacy and safety of PCEA using a large da-
tabase in Korea. We thus evaluated the efficacy and safety 
of PCEA using our large institutional database. This study 
is a retrospective observational audit of 2276 patients who 
received PCEA for postoperative analgesia in general sur-
gical wards in Korea.
MATERIALS AND METHODS
This study was approved by our hospital’s Institutional 
Review Board (ref. 4-2012-0201). The sample population 
was defined as elective surgical patients who received 
PCEA with ropivacaine and fentanyl for postoperative pain 
control between September 2010 and December 2011 at our 
hospital. Exclusion criteria were the following: age less 
than 18 years, other regimen of PCEA, and requirement 
of postoperative ventilator support or intensive care.
Epidural catheters were inserted before or after sur-
gery at a vertebral level corresponding to the dermatomal 
level of the surgical incision. An 18-G Tuohy needle and 
20-G epidural catheter were used (B. Brown Co., PA, USA). 
A loss of resistance technique was used to identify the epi-
dural space, and the epidural catheter was inserted to the 
proper depth in the epidural space. Adhesive tape 
(Tegaderm; 3M, MN, USA) was used to affix the catheter 
along the patient’s back, followed by an aseptic dressing. 
General or regional (spinal) anesthesia was conducted at 
the discretion of attending anesthesiologists. All patients 
used a disposable PCA pump (Accufuser plusⓇ; Woo Young 
Medical, Korea), which was programmed to deliver 5 ml/hr 
(or 2 ml/hr) as a background infusion and 2.0 ml (or 0.5 
ml) on demand, with a 15 min lockout during a 48 h period. 
The PCA regimen typically composed of fentanyl (2-5 
μg/ml) plus ropivacaine (0.15-0.20%). The PCA service 
team, which was comprised of anesthesiologists and PCA 
nurse specialists, monitored patients in the post-anes-
thesia care unit (PACU), at 1-6, 6-24, and 24-48 h inter-
vals after surgery to inquire about the occurrence of ad-
verse events, and the needs for rescue IV analgesics 
(ketolorac, tramadol, meperidine). PCEA-related adverse 
events included numbness, motor weakness, nausea and 
vomiting, sedation, dizziness, headache, hypotension 
(systolic blood pressure ＜ 90 mmHg), pruritus, infection, 
respiratory depression and mechanical catheter problems. 
In addition to these parameters, patients were asked to 
rate their worst pain intensity during each time period. 
Pain intensity scores were measured on a numerical rating 
scale (0 = no pain to 10 = worst pain imaginable). The 
PCEA was stopped for approximately 2 h if side effects or 
complications of PCEA were not relieved by any treat-
ments, and the PCEA was completely discontinued when 
side effects or complications persisted with the resumption 
of PCEA and/or at the request of the patient. The PCA 
service team recorded the reason for cessation, time of 
cessation, adverse side effects, and residual volume of 
PCEA if it was discontinued within 48 h of surgery. Elective 
completion of PCEA is defined as PCEA being maintained 
during postoperative 48 h until the PCEA was finished. 
Additional patient data that were collected included age, 
gender, height, weight, body mass index (BMI), medical 
history, duration of anesthesia, type of anesthesia, and 
type of surgery. 
Corrections and insertion of missing data were per-
formed by checking the original documentation sheets or 
hospital medical records. Continuous variables are shown 
as mean ± SD, and categorical variables are shown as 
a number (percentage). Nonparametric data were analyzed 
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Table 1. Patient Characteristics, Anesthetic and Surgical Data  
Surgery type N (%) Age (yr)
Gender, 
Male/Female
Weight (kg) BMI (kg/m2)
Anesthesia type,
General/Regional
Duration of 
anesthesia 
(min)
Elective 
completion of 
PCEA (%)
Abdominal
Gynecologic
Urologic
Thoracic
Orthopedic
Overall
1,120 (49)
203 (9)
137 (6)
 76 (3)
 740 (32)
2,276
57.9 ± 11.9
36.8 ± 10.1
62.1 ± 13.6
51.7 ± 15.3
59.7 ± 17.5
56.7 ± 15.4
728/392
  0/203
108/29
55/21
224/516
1,115/1,161
62.1 ± 10.5
66.5 ± 10.8
65.4 ± 10.2
63.0 ± 12.1
63.7 ± 10.9
63.2 ± 10.8
22.9 ± 3.1
25.7 ± 3.6
23.8 ± 3.0
22.8 ± 3.6
25.1 ± 3.4
23.9 ± 3.4
1,072/48
 53/150
121/16
76/0
 71/669
1,393/883
227.6 ± 87.8
142.2 ± 79.6
241.9 ± 97.0
198.7 ± 69.1
142.5 ± 71.9
192.2 ± 92.5
92
82
83
86
78
86
Values are mean ± SD or number (percentage) of patients. PCEA: patient-controlled epidural analgesia.
Fig. 1. Study profile.
using Fisher’s exact test or the chi-square test. Because 
pain intensity may depend on the type of surgery, pain 
scores were compared in subgroup analyses. Owing to the 
fact that the data were not normally distributed, the 
Kruskal-Wallis test and the Friedman test with post-hoc 
testing using the Wilcoxon rank-sum test were used to 
compare groups. Statistical analysis was performed with 
SAS (version 9.2; SAS Institute, Inc., Cary, NC, USA). Values 
of P ＜ 0.05 were considered statistically significant.
RESULTS
A total of 2,885 patients were assessed for study eligi-
bility, of whom 2,276 met study criteria and were finally 
analyzed in this observational study. There were 329 pa-
tients (14%) for whom PCEA was terminated within 48 h 
after surgery due to PCEA-related adverse events. In the 
cessation population, PCEA was ceased in 8%, 43%, and 
49% of patients at 1-6, 6-24, and 24-48 h after surgery, 
respectively (Fig. 1). 
The type of surgery the patients received is listed in 
Table 1, along with patients characteristics, anesthesia 
type, duration of anesthesia, and elective completion rate 
of PCEA for each surgery type. Completion of PCEA 
(continuing until the PCEA was finished) was elective in 
86% of patients in the postoperative 48 h. Patients who 
underwent orthopedic surgery showed the lowest elective 
completion rate of PCEA. The mean concentration of fen-
tanyl and ropivacaine were 3.04 ± 1.87 μg/ml and 0.16 
± 0.04%, respectively. A PCA device with a 5 ml/hr in-
fusion rate was used in 91% of patients and a device with 
a 2 ml/hr rate was used in 9%. There were no statistically 
significant differences in pain scores (3 [1-4] vs. 3 [1-4], 
5 [4-7] vs. 5 [4-6], 4 [3-5] vs. 4 [3-5], and 3 [3-5] vs. 
3 [3-5]) and cessation rate (12% vs. 14%, P = 0.091) be-
tween the two types of PCA device (infusion rate 2 ml/hr 
vs. 5 ml/hr). The fentanyl dose delivered hourly was 13.3 
± 5.6 μg/hr. Numerical pain scores with the median and 
the inter-quartile range according to type of surgical pro-
cedure in the PACU, at postoperative 1-6, 6-24, and 
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Fig. 2. Comparison between numerical pain scores accor-
ding to the type of surgery at postoperative assessment 
intervals. The box plot displays 10th, 25th, median (fat bars),
75th, and 90th percentiles of values. PACU: post-anesthesia
care unit. *P ＜ 0.05 using the Friedman test with post-hoc
testing using the Wilcoxon rank-sum test with Bonferroni 
correction.
Table 2. PCEA Related Side Effects 
Surgery type
Epidural
location
No. of 
patients
Side effects
Nausea and 
vomiting
Numbness
Headache 
and dizziness
Hypotension
Motor 
weakness
Pruritus Sedation
Abdominal
Gynecologic
Urologic
Thoracic
Orthopedic
Overall
Thoracic 
Lumbar
Thoracic 
Lumbar 
Thoracic 
Lumbar 
Thoracic 
Lumbar
Thoracic 
Lumbar
Thoracic 
Lumbar 
Total 
878
242
  4
199
 41
 96
 72
  4
  3
737
998
1,278
2,276
96
38
 0
22
 8
21
20
 1
 1
267
125 (12.5)
 349 (27.3)*
474 (20.8)
20
26
 0
68
 5
16
 3
 0
 0
130
30 (3.0)
 238 (18.6)*
268 (11.7)
60
12
 1
 7
 2
 7
 4
 1
 0
49
 67 (6.7)
 76 (5.9)
143 (6.2)
85
13
 0
 4
 3
 3
 2
 0
 0
18
 90 (9.0)*
38 (2.9)
128 (5.6)
 7
16
 0
28
 1
 6
 2
 0
 0
29
10 (1.0)
79 (6.1)
89 (3.9)
42
 7
 0
 4
 1
 0
 1
 0
 0
12
 44 (4.4)*
23 (1.7)
67 (2.9)
2
0
0
0
0
0
0
0
0
2
2 (0.2)
2 (0.2)
4 (0.1)
Values are number (percentage) of patients. PCEA: patient-controlled epidural analgesia. *P ＜ 0.05 significant difference in the incidence
of PCEA related side effects between thoracic and lumbar PCEA.  
24-48 h assessment intervals are shown in Fig. 2. In the 
PACU and the postoperative 1-6 h period, median pain 
scores in patients who underwent major abdominal surgery 
or thoracic surgery were higher than those for other sur-
gical types (P ＜ 0.05 using the Friedman test with 
post-hoc testing using the Wilcoxon rank-sum test with 
the Bonferroni correction). The percentages of patients 
who received rescue analgesic were 15%, 55%, 41%, and 
15% at each assessment intervals. The percentages of pa-
tients with clinically adequate analgesia (numerical pain 
score ≤ 3) were 71%, 38.6%, 61.1%, and 72.8% at each 
assessment intervals. Comparison between numerical pain 
scores according to type of anesthesia in the PACU, at 
postoperative 1-6, 6-24, and 24-48 h assessment inter-
vals for each surgery type is shown in Fig. 3. Patients who 
underwent surgery under regional anesthesia showed lower 
median pain scores than those who underwent general an-
esthesia in the PACU, postoperative 1-6 h period (P ＜ 
0.001). Patients who underwent general anesthesia suf-
fered more postoperative pain than those who underwent 
regional anesthesia regardless of surgery type. PCEA-re-
lated side effects according to type of surgical procedure 
and the insertion site of PCEA are listed in Table 2. Overall, 
474 patients (20.8%) experienced nausea and emetic 
symptoms (vomiting or retching) during the postoperative 
48 h, and the number of patients with nausea or emetic 
symptoms was 51, 330, 304, an 128 patients at each as-
sessment intervals. The incidence of numbness and motor 
weakness was significantly higher with lumbar catheters 
than which thoracic catheters (P ＜ 0.001). Hypotension 
and pruritus showed significantly higher incidence with 
thoracic catheters than which lumbar catheters (P ＜ 
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Table 3. Reasons for Cessation of PCEA Within the Postoperative
48 h (n = 329)
Main reasons
N (% of 329 
cessation patients)
% of 2,276 
patients
Nausea and vomiting
Numbness or motor weakness
Catheter disconnected at filter
Catheter migration/pull out
Hypotension 
Headache or dizziness 
Urinary retention 
Leak at insertion site
Pruritus 
Pain at insertion site  
Accidental removal by patient
No cause identified 
 91 (27.6)
 87 (26.4)
 38 (11.5)
32 (9.7)
23 (6.9)
17 (5.1)
13 (3.9)
13 (3.9)
10 (3.0)
 2 (0.6)
 2 (0.6)
 1 (0.3)
3.99
3.82
1.67
1.40
1.01
0.74
0.57
0.57
0.44
0.08
0.08
0.04
Values are number (percentage) of patients. PCEA: patient-controlled
epidural analgesia.
Fig. 3. Comparison between numerical pain scores according to the type of anesthesia (general vs. regional) at postoperative
assessment intervals for each surgery type. The box plot displays 10th, 25th, median (fat bars), 75th, and 90th percentiles
of values. PACU: post-anesthesia care unit. *P ＜ 0.05 vs. regional anesthesia using the Friedman test.
0.001). Reasons for cessation of PCEA within the post-
operative 48 h are listed in Table 3. Cessation of PCEA 
was defined as patients being unable to maintain PCEA 
during the postoperative 48 h due to side effects or 
complications. Nausea/emetic symptoms, numbness/motor 
weakness, and catheter-related mechanical problems were 
found to be major causes of premature cessation of PCEA 
within the postoperative 48 h. Mechanical problems that 
were observed included catheter migration/pull out (9.7%) 
and disconnection at the filter (11.5%).
DISCUSSION 
The present study is the largest observational single- 
center analysis of postoperative PCEA published yet in 
Korea. Our data suggest that the use of PCEA with ropi-
vacaine and fentanyl provides relatively adequate analgesia 
in the postoperative 48 h period after a wide variety of 
surgical procedures and is associated with few serious 
complications. However, more careful pain management 
and sustainable PCEA monitoring may be required in pa-
tients using PCEA in general surgical wards.
Although PCEA may provide better postoperative an-
algesia compared with on-demand parental opioids, IV-PCA, 
or peripheral nerve block, many patients using PCEA also 
experienced some postoperative pain in the immediate 
postoperative period [6]. Our data show that pain scores 
and analgesic requirements were high in the first 24 h fol-
lowing surgery, which is consistent with previous studies 
[6,8-10]. However, our patients using PCEA suffered more 
postoperative pain, based on pain scores in the post-
operative 24 h period, than was observed in controlled 
prospective studies conducted in similar PCEA environ-
ments [8]. Moreover, patients who underwent major ab-
dominal or thoracic surgery experienced more pain com-
pared with those who underwent other surgical procedures 
in the immediate postoperative period. There are several 
explanations for these results. In this study, the lower dose 
of fentanyl used in the PCEA may contribute to the lower 
efficacy of pain relief compared to previous study out-
comes. The hourly delivered fentanyl dose in our study was 
30%-70% of that used in previous studies [8,9]. In addi-
tion, the use of a fixed-setting PCA device in our study 
population might affect pain intensity. Most previous epi-
dural analgesia studies were conducted using adjustable- 
setting PCA devices, which allow more flexibility in the 
timing and amount of dose delivered [8-10]. We routinely 
used a bolus dose of local anesthetics via epidural catheter 
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at the discretion of attending anesthesiologists toward the 
end of the surgical period [11]. This practice provided more 
adequate analgesia and led to lower analgesic require-
ments in patients with PCEA in the PACU. In the same 
manner, more aggressive pain management via the epi-
dural route is especially needed in patients who undergo 
major abdominal or thoracic surgery for better post-
operative analgesia within the immediate postoperative 
period. 
Our data showed that nausea and vomiting were major 
PCEA-related side effects and that these resulted in pre-
mature cessation of PCEA in many cases. Previous studies 
reported a high incidence of nausea and vomiting in pa-
tients who received epidural analgesia with opioids [8,10]. 
We are aware of one study regarding PCEA-related nausea 
and vomiting, in which female gender was suggested as a 
possible risk factor for PCEA related nausea and vomiting 
[8]. In our population, 91 patients prematurely discontinued 
PCEA due to intractable nausea and vomiting, and 65% of 
these were female. Multimodal prophylactic antiemetic 
strategies may be considered as strategies for the pre-
vention of PCEA-related nausea and vomiting, especially 
in female patients. Numbness and motor weakness are the 
side effects most attributable to epidural analgesia [3]. 
Thoracic placement of the epidural catheter produced both 
less numbness and less motor weakness than lumbar 
placement in our study, which is consistent with previous 
studies [3,8]. According to previous studies, low lumbar 
(L4-L5) administration of epidural local anesthetics in-
creased the incidence of lower limbs motor block compared 
with high lumbar administration (L1-L2), and numbness 
and motor weakness were significantly associated with the 
concentration of local anesthetics [12-15]. Additionally, the 
migration of the epidural catheter toward the nerve root 
is a possible risk factor for PCEA-related numbness and 
motor weakness [15]. Therefore, careful placement of the 
epidural catheter and judicious consideration of the con-
centration of local anesthetics to be used in the PCEA reg-
imen are required in the lumbar approach. Most previous 
studies analyzing epidural analgesia observed a wide var-
iation in the incidence/severity of hypotension [3,8-10]. In 
our study, thoracic epidural analgesia resulted in a higher 
incidence of hypotension than lumbar epidural analgesia. 
These results may be explained by an anatomical differ-
ence between the thoracic and lumbar epidural spaces [16]. 
The thoracic epidural space contains less fat, and the 
thoracic dura is less adhere to the surrounding bony canal 
than in the lumbar epidural space. Moreover, sympathetic 
block may aggravate hypotension [6]. We also found that 
mechanical problems including dislodgement of the cathe-
ter and disconnection at the filter accounted for 21% of 
premature cessation of PCEA. Interestingly, patients who 
underwent orthopedic or obstetrics and gynecologic sur-
gery, who required early ambulation and exercise in the 
postoperative period, were especially prone to prematurely 
cease PCEA due to mechanical problems in our study. The 
incidence of mechanical problems with PCEA was reported 
to be approximately 13-23% in large-scale studies 
[9,17,18]. Various methods of reinforcing the dressing have 
been described to attempt to reduce and prevent these 
problems [17]. Other mechanical problems due to occlusion, 
kinking, or PCA device malfunction may cause accidental 
discontinuation of PCEA. More meticulous dressing and 
fixation of the epidural catheter with adhesive materials, 
as well as sustainable management, will reduce PCEA-re-
lated mechanical problems. In addition, we cannot over-
emphasize the importance of improved education of physi-
cians and nursing staff regarding prevention and manage-
ment of various mechanical problems related to PCEA. In 
our study, sedation was observed in 4 (0.2%) patients, 
without respiratory depression. These patients were 
slightly drowsy and were managed by a temporary cessa-
tion of PCEA. There were no cases of serious epidural 
catheter-related complications, such as respiratory de-
pression, epidural hematoma or abscess, local inflam-
mation, or permanent neurologic damage in our popu-
lation. Despite their low incidence, most studies reported 
these serious complications that could threaten the safety 
of patients [6,9,10]. These problems are known to closely 
associate with high opioid infusion or bolus dose and long 
duration of placement of the epidural catheter [17]. The 
optimal concentration of fentanyl for PCEA infusion is not 
known, although the majority of studies dealing with epi-
dural fentanyl report that doses of fentanyl of 4-10 μg/ml 
and 1 μg/ml in combination with bupivacaine were fre-
quently inadequate analgesia and required high infusion 
rates [9]. Decreased use of local anesthetics and opioids 
with PCEA with equivalent analgesia would be valuable if 
drug-related side effects could be reduced [19]. A highly 
significant increase in inflammatory complications has 
been reported in case in which an epidural catheter is in 
place for four or more days [17]. We used a fixed-setting 
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PCA device with an average fentanyl concentration of 3.0 
μg/ml for 2 days postoperatively.
This study has some limitations. Being observational 
in nature, this study used the real-world clinical practice 
model in which attending physicians decided on the place-
ment of epidural catheters and the prescription of the PCA 
regimen, as well as the use and cessation of PCEA on the 
general ward, according to institutional guidelines. There-
fore, the decision to administer the PCA regimen and to 
cease PCEA could have been influenced by the attending 
physician’s judgment and preconceptions concerning PCEA. 
Also, we cannot precisely measure ropivacaine and fen-
tanyl requirements in individual patients considering the 
bolus and infusion doses of PCEA. Therefore, further stud-
ies will be required to take these limitations into consid-
eration and conduct more controlled observations of PCEA 
in Korea. 
In conclusion, our study demonstrated that PCEA pro-
vides relatively effective and safe postoperative analgesia. 
More careful management of PCEA considering various in-
dividual factors, however, may be needed to ensure max-
imal benefit for all patients. 
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